PDL BioPharma, Inc. Deferred Tax Liabilities, Net
PDL BioPharma, Inc. had Deferred Tax Liabilities, Net of $19.92 million as of 2020-12-31, per its 10-K filed 2021-03-29.
Discontinued › Notes › Income Taxes › Components of Deferred Tax Assets and Liabilities › Deferred Tax Liabilities, Net
us-gaap:DeferredTaxLiabilities · last filed 2021-03-29
- 2020-12-31: Deferred Tax Liabilities, Net $19.92M.
- 2020-06-30: Deferred Tax Liabilities, Net $1.41M.
- 2020-03-31: Deferred Tax Liabilities, Net $2.10M.
- 2019-12-31: Deferred Tax Liabilities, Net $1.57M; Deferred Tax Liabilities, Net as first filed $484.00K.
| Period end | Deferred Tax Liabilities, Net | Deferred Tax Liabilities, Net as first filed |
|---|---|---|
| 2020-12-31 | $19.92M 10-K · filed 2021-03-29 | |
| 2020-06-30 | $1.41M 10-Q · filed 2020-08-07 | |
| 2020-03-31 | $2.10M 10-Q · filed 2020-05-11 | |
| 2019-12-31 | $1.57M 10-K · filed 2021-03-29 | $484.00K 10-K · filed 2020-03-11 |
| 2018-12-31 | $14.08M 8-K · filed 2020-06-29 | $12.31M 10-K · filed 2019-03-15 |